Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective

被引：5
|
作者：
Bernicker, Eric [1 ]
机构：
[1] Houston Methodist Hosp, Thorac Med Oncol, Houston, TX 77030 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2015年 / 139卷 / 04期
关键词：
PHASE-II TRIAL; 1ST-LINE TREATMENT; OPEN-LABEL; EGFR; CHEMOTHERAPY; MUTATIONS; ERLOTINIB; CARBOPLATIN; COMBINATION; PACLITAXEL;
D O I：
10.5858/arpa.2014-0085-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [1] Non-small cell lung carcinoma biomarker testing: the pathologist's perspective
    Brega, Elisa
    Brandao, Guilherme
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [2] Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
    Malapelle, Umberto
    Tiseo, Marcello
    Vivancos, Ana
    Kapp, Joshua
    Jose Serrano, M.
    Tiemann, Markus
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (03): : 255 - 273
  • [3] Challenges and controversies in resectable non-small cell lung cancer: a clinician's perspective
    Houda, Ilias
    Dickhoff, Chris
    Uyl-de Groot, Carin A.
    Damhuis, Ronald A. M.
    Reguart, Noemi
    Provencio, Mariano
    Levy, Antonin
    Dziadziuszko, Rafal
    Pompili, Cecilia
    Di Maio, Massimo
    Thomas, Michael
    Brunelli, Alessandro
    Popat, Sanjay
    Senan, Suresh
    Bahce, Idris
    LANCET REGIONAL HEALTH-EUROPE, 2024, 38
  • [4] Current communication practices for biomarker testing in non-small cell lung cancer: Exploring patient and clinician perspectives
    Pack, Allison
    Russell, Andrea
    Kircher, Sheetal
    Weldon, Christine
    Bailey, Stacy C.
    Lockwood, Karen
    Marquart, Tyler
    Afonso, Ana Sofia
    Payakachat, Nalin
    Wolf, Michael
    PATIENT EDUCATION AND COUNSELING, 2023, 114
  • [5] Non-Small Cell Lung Cancer: Recommendations for Biomarker Testing and Treatment
    Aisner, Dara L.
    Riely, Gregory J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 610 - 613
  • [6] Biomarker testing in non-small cell lung cancer: to move forward with quality
    Rolf Stahel
    Clinical and Translational Oncology, 2012, 14 : 321 - 322
  • [7] The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
    Kerr, Keith M.
    Bibeau, Frederic
    Thunnissen, Erik
    Botling, Johan
    Ryska, Ales
    Wolf, Jurgen
    Ohrling, Katarina
    Burdon, Peter
    Malapelle, Umberto
    Buttner, Reinhard
    LUNG CANCER, 2021, 154 : 161 - 175
  • [8] Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
    Ganti, Apar
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ramalingam, Suresh
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Borghaei, Hossein
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S964 - S965
  • [9] Biomarker testing in non-small cell lung cancer: to move forward with quality
    Stahel, Rolf
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (05): : 321 - 322
  • [10] What, When, and How of Biomarker Testing in Non-Small Cell Lung Cancer
    Riely, Gregory L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 686 - 688
12345